OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
Bożena Katarzyna Budziszewska, Aleksander Salomon‐Perzyński, Katarzyna Pruszczyk, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4189-4189
Open Access | Times Cited: 9
Bożena Katarzyna Budziszewska, Aleksander Salomon‐Perzyński, Katarzyna Pruszczyk, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4189-4189
Open Access | Times Cited: 9
Showing 9 citing articles:
Current status and research directions in acute myeloid leukemia
Hagop M. Kantarjian, Gautam Borthakur, Naval Daver, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Hagop M. Kantarjian, Gautam Borthakur, Naval Daver, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Acute myeloid leukemia management and research in 2025
Hagop M. Kantarjian, Courtney D. DiNardo, Tapan M. Kadia, et al.
CA A Cancer Journal for Clinicians (2024)
Open Access | Times Cited: 7
Hagop M. Kantarjian, Courtney D. DiNardo, Tapan M. Kadia, et al.
CA A Cancer Journal for Clinicians (2024)
Open Access | Times Cited: 7
Describing the outcomes of frail patients undergoing treatment with systemic therapies for acute myeloid leukaemia: A systematic review
Aaron Sia, Sakshi Chopra, Victoria Y. Ling, et al.
Journal of Geriatric Oncology (2025) Vol. 16, Iss. 3, pp. 102196-102196
Closed Access
Aaron Sia, Sakshi Chopra, Victoria Y. Ling, et al.
Journal of Geriatric Oncology (2025) Vol. 16, Iss. 3, pp. 102196-102196
Closed Access
Non-intensive acute myeloid leukemia therapies for older patients
Rodrick Babakhanlou, Farhad Ravandi
Expert Review of Hematology (2023) Vol. 16, Iss. 3, pp. 171-180
Closed Access | Times Cited: 7
Rodrick Babakhanlou, Farhad Ravandi
Expert Review of Hematology (2023) Vol. 16, Iss. 3, pp. 171-180
Closed Access | Times Cited: 7
Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression
Scott S. Auerbach, Beana Puka, Upendarrao Golla, et al.
Life (2024) Vol. 14, Iss. 3, pp. 309-309
Open Access | Times Cited: 2
Scott S. Auerbach, Beana Puka, Upendarrao Golla, et al.
Life (2024) Vol. 14, Iss. 3, pp. 309-309
Open Access | Times Cited: 2
Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations
Daniil E. Shabashvili, Yang Feng, Prabhjot Kaur, et al.
Experimental Hematology (2022) Vol. 110, pp. 20-27
Open Access | Times Cited: 6
Daniil E. Shabashvili, Yang Feng, Prabhjot Kaur, et al.
Experimental Hematology (2022) Vol. 110, pp. 20-27
Open Access | Times Cited: 6
Ribonucleotide reductase: Implications of thiol S-nitrosylation and tyrosine nitration for different subunits
Surupa Chakraborty, Prerona Mukherjee, Rajib Sengupta
Nitric Oxide (2022) Vol. 127, pp. 26-43
Closed Access | Times Cited: 5
Surupa Chakraborty, Prerona Mukherjee, Rajib Sengupta
Nitric Oxide (2022) Vol. 127, pp. 26-43
Closed Access | Times Cited: 5
Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review
Qiukui Hao, Farid Foroutan, Mi Ah Han, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278578-e0278578
Open Access | Times Cited: 4
Qiukui Hao, Farid Foroutan, Mi Ah Han, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278578-e0278578
Open Access | Times Cited: 4
Efficacy and feasibility of Pharmacoscopy-guided treatment for acute myeloid leukemia patients that exhausted all registered therapeutic options
Jonas Schmid, Yasmin Festl, Yannik Severin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Jonas Schmid, Yasmin Festl, Yannik Severin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
